D J Nathaniel

425 total citations
9 papers, 355 citations indexed

About

D J Nathaniel is a scholar working on Physiology, Immunology and Nutrition and Dietetics. According to data from OpenAlex, D J Nathaniel has authored 9 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Immunology and 3 papers in Nutrition and Dietetics. Recurrent topics in D J Nathaniel's work include Immune Response and Inflammation (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). D J Nathaniel is often cited by papers focused on Immune Response and Inflammation (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). D J Nathaniel collaborates with scholars based in Canada, Japan and United States. D J Nathaniel's co-authors include Jillian F. Evans, Robert Zamboni, A. W. Ford‐Hutchinson, Claire Leveillé, Brian J. Fitzsimmons, Denis Riendeau, Yves Leblanc, Anthony W. Ford‐Hutchinson, Joshua Rokach and Jean‐Pierre Falgueyret and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

D J Nathaniel

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D J Nathaniel Canada 9 132 105 88 85 65 9 355
Sandra F. Falkenhein United States 9 194 1.5× 126 1.2× 46 0.5× 85 1.0× 119 1.8× 13 452
K A Chandrabose United States 8 67 0.5× 135 1.3× 42 0.5× 92 1.1× 60 0.9× 11 418
Pierre Vallerand Canada 10 205 1.6× 155 1.5× 62 0.7× 142 1.7× 153 2.4× 10 530
Linda Backman Sweden 6 96 0.7× 109 1.0× 37 0.4× 84 1.0× 85 1.3× 6 331
Jane Marsh United Kingdom 7 118 0.9× 141 1.3× 228 2.6× 90 1.1× 12 0.2× 9 477
Susanne Tornhamre Sweden 12 82 0.6× 94 0.9× 20 0.2× 38 0.4× 55 0.8× 15 359
Hitoshi Fujimori Japan 9 89 0.7× 99 0.9× 27 0.3× 27 0.3× 114 1.8× 15 350
S Yamamoto United Kingdom 9 43 0.3× 79 0.8× 27 0.3× 34 0.4× 120 1.8× 18 351
Shigeru Sugino Japan 10 59 0.4× 84 0.8× 63 0.7× 13 0.2× 69 1.1× 33 362
Kenneth J. Serio United States 11 92 0.7× 136 1.3× 19 0.2× 34 0.4× 101 1.6× 15 378

Countries citing papers authored by D J Nathaniel

Since Specialization
Citations

This map shows the geographic impact of D J Nathaniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Nathaniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Nathaniel more than expected).

Fields of papers citing papers by D J Nathaniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D J Nathaniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Nathaniel. The network helps show where D J Nathaniel may publish in the future.

Co-authorship network of co-authors of D J Nathaniel

This figure shows the co-authorship network connecting the top 25 collaborators of D J Nathaniel. A scholar is included among the top collaborators of D J Nathaniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D J Nathaniel. D J Nathaniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kargman, Stacia, Philippe Rousseau, Carol A. Rouzer, et al.. (1993). Leukotriene synthesis in U937 cells expressing recombinant 5-lipoxygenase.. PubMed. 7(1). 31–45. 21 indexed citations
2.
Riendeau, Denis, Jean‐Pierre Falgueyret, D J Nathaniel, & Joshua Rokach. (1989). Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides. Biochemical Pharmacology. 38(14). 2313–2321. 39 indexed citations
3.
Riendeau, Denis, et al.. (1989). Stimulation of 5-lipoxygenase activity under conditions which promote lipid peroxidation. Biochemical Journal. 263(2). 565–572. 37 indexed citations
4.
Evans, Jillian F., Y. LEBLANC, Brian J. Fitzsimmons, et al.. (1987). Activation of leukocyte movement and displacement of [3H]leukotriene B4 from leukocyte membrane preparations by (12R)-and (12S)-hydroxyeicosatetraenoic acid. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 917(3). 406–410. 44 indexed citations
5.
Evans, Jillian F., D J Nathaniel, S. Charleson, et al.. (1986). Neutrophil LTA4 hydrolases and leukotriene B4 receptors: Effects of leukotriene epoxides and their enzymatic products. Prostaglandins Leukotrienes and Medicine. 23(2-3). 167–171. 12 indexed citations
6.
Evans, Jillian F., Robert Zamboni, D J Nathaniel, Claire Leveillé, & A. W. Ford‐Hutchinson. (1985). Characterization of biological properties of synthetic and biological leukotriene B3. Prostaglandins. 30(6). 981–988. 9 indexed citations
7.
Nathaniel, D J, Jillian F. Evans, Yves Leblanc, et al.. (1985). Leukotriene A 5 is a substrate and an inhibitor of rat and human neutrophil LTA 4 hydrolase. Biochemical and Biophysical Research Communications. 131(2). 827–835. 67 indexed citations
8.
Evans, Jillian F., D J Nathaniel, Robert Zamboni, & A. W. Ford‐Hutchinson. (1985). Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase.. Journal of Biological Chemistry. 260(20). 10966–10970. 107 indexed citations
9.
Chan, C C, et al.. (1984). Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035).. Journal of Pharmacology and Experimental Therapeutics. 229(1). 276–282. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026